Antioxidative peptide from milk exhibits antiosteopenic effects through inhibition of oxidative damage and bone-resorbing cytokines in ovariectomized rats

Nutrition

Volumn 43-44, Issue , 2017, Pages 21-31

  Mada, Sanusi Bello ^a,b   Reddi, Srinu ^a   Kumar, Naveen ^a   Kumar, Rohit ^a   Kapila, Suman ^a   Kapila, Rajeev ^a   Trivedi, Ritu ^c   Karvande, Anirudha ^c   Ahmad, Naseer ^c  

^a NATIONAL DAIRY RESEARCH INSTITUTE   (India)

^b AHMADU BELLO UNIVERSITY   (Nigeria)

^c CENTRAL DRUG RESEARCH INSTITUTE   (India)

Author keywords

Antioxidative; Bone resorbing cytokine; Ovariectomized rat; Oxidative damage; Peptide (VLPVPQK); Postmenopausal osteoporosis

Indexed keywords

ALKALINE PHOSPHATASE; ANTIOXIDANT; BIOLOGICAL MARKER; CATALASE; CYTOKINE; GLUTATHIONE; MALONALDEHYDE; OSTEOCALCIN; PARATHYROID HORMONE; PEPTIDE; SUPEROXIDE DISMUTASE; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR; UNCLASSIFIED DRUG; VALYLLEUCYLPROLYLVALYLPROLYLGLUTAMYLLYSINE; CASEIN; MILK PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOSTEOPENIC ACTIVITY; ARTICLE; ASH; BONE DENSITY; BONE STRENGTH; BONE TURNOVER; CALCIUM BLOOD LEVEL; CONTROLLED STUDY; DRUG ACTIVITY; DRUG MECHANISM; DRY WEIGHT; ENDOMETRIUM ATROPHY; ENZYME ACTIVITY; FEMALE; FEMUR DRY WEIGHT; MUSCULOSKELETAL SYSTEM PARAMETERS; NONHUMAN; OSTEOLYSIS; OXIDATIVE STRESS; POSTMENOPAUSE OSTEOPOROSIS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RAT; TRABECULAR BONE; UTERUS WEIGHT; WEIGHT GAIN; WEIGHT REDUCTION; ANIMAL; ANTAGONISTS AND INHIBITORS; BONE REMODELING; BUFFALO; CHEMISTRY; DRUG EFFECT; FEMUR; HUMAN; MILK; OVARIECTOMY; PREVENTION AND CONTROL; TIBIA; WISTAR RAT;

ANIMALS; ANTIOXIDANTS; BONE DENSITY; BONE REMODELING; BONE RESORPTION; BUFFALOES; CASEINS; CYTOKINES; FEMALE; FEMUR; HUMANS; MILK; MILK PROTEINS; OSTEOPOROSIS, POSTMENOPAUSAL; OVARIECTOMY; OXIDATIVE STRESS; PEPTIDES; RATS; RATS, WISTAR; TIBIA;

EID: 85026827216     PISSN: 08999007     EISSN: 18731244     Source Type: Journal    
DOI: 10.1016/j.nut.2017.06.010     Document Type: Article

References (58)

1. Vijayan, V., Khandelwal, M., Manglani, K., Singh, R.R., Gupta, S., Surolia, A., Homocysteine alters the osteoprotegerin/RANKL system in the osteoblast to promote bone loss: pivotal role of the redox regulator forkhead O1. Free Radic Biol Med 16 (2013), 72–84.
2. Huang, Q., Shi, J., Gao, B., Zhang, H.Y., Fan, J., Li, X.J., et al. Gastrodin: an ancient Chinese herbal medicine as a source for anti-osteoporosis agents via reducing reactive oxygen species. Bone 73 (2015), 132–144.
3. Rachner, T.D., Khosla, S., Hofbauer, L.C., Osteoporosis: now and the future. Lancet 377 (2011), 1276–1287.
4. Maggio, D., Barabani, M., Pierandrei, M., Polidori, M.C., Catani, M., Mecocci, P., et al. Marked decrease in plasma antioxidants in aged osteoporotic women: results of a cross-sectional study. J Clin Endocrinol Metab 88 (2003), 1523–1527.
5. Almeida, M., Han, L., Martin-Millan, M., Plotkin, L.I., Stewart, S.A., Roberson, P.K., et al. Skeletal involution by age-associated oxidative stress and its acceleration by loss of sex steroids. J Biol Chem 282 (2007), 27285–27297.
6. Baek, K.H., Oh, K.W., Lee, W.Y., Lee, S.S., Kim, M.K., Kwon, H.S., et al. Association of oxidative stress with postmenopausal osteoporosis and the effects of hydrogen peroxide on osteoclast formation in human bone marrow cell cultures. Calcif Tissue Int 87 (2010), 226–235.
7. Witko-Sarsat, V., Friedlander, M., Capeillere-Blandin, C., Nguyen-Khoa, T., Nguyen, A.T., Zingraff, J., et al. Advanced oxidation protein products as a novel marker of oxidative stress in uremia. Kidney Int, 49, 1996, 1304.
8. Ozgocmen, S., Kaya, H., Fadillioglu, E., Aydogan, R., Yilmaz, Z., Role of antioxidant systems, lipid peroxidation, and nitric oxide in postmenopausal osteoporosis. Mol Cell Biochem 295 (2007), 45–52.
9. Jagger, C.J., Lean, J.M., Davies, J.T., Chambers, T.J., Tumor necrosis factor-α mediates osteopenia caused by depletion of antioxidants. Endocrinology 146 (2005), 113–118.
10. Charatcharoenwitthaya, N., Khosla, S., Atkinson, E.J., McCready, L.K., Riggs, B.L., Effect of blockade of TNF–α and Interleukin-1 action on bone resorption in early postmenopausal women. J Bone Miner Res 22 (2007), 724–729.
11. Korhonen, H., Pihlanto, A., Bioactive peptides: production and functionality. Int Dairy J 16 (2006), 945–960.
12. Mao, X., Cheng, X., Wang, X., Wu, S., Free-radical-scavenging and anti-inflammatory effect of yak milk casein before and after enzymatic hydrolysis. Food Chem 126 (2011), 484–490.
13. Haque, E., Chand, R., Kapila, S., Biofunctional properties of bioactive peptides of milk origin. Food Rev Int 25 (2009), 28–43.
14. Chee, W.S.S., Suriah, A.R., Chan, S.P., Zaitun, Y., Chan, Y.M., The effect of milk supplementation on bone mineral density in postmenopausal Chinese women in Malaysia. Osteoporos Int 14 (2003), 828–834.
15. Matkovic, V., Landoll, J.D., Badenhop-Stevens, N.E., Ha, E.Y., Crncevic-Orlic, Z., Li, B., et al. Nutrition influences skeletal development from childhood to adulthood: A study of hip, spine and forearm in adolescent females. J Nutr 134 (2004), 7015–7055.
16. Behera, P.S., Kumar, R., Sandeep, I.V.R., Kapila, R., Dang, A.K., Kapila, S., Casein hydrolysates enhances osteoblast proliferation and differentiation in mouse bone marrow culture. Food Bioscience 2 (2013), 24–30.
17. Shanmugam, V.P., Kapila, S., Kemgang, T.S., Kapila, R., Antioxidative peptide derived from enzymatic digestion of buffalo casein. Int Dairy J 42 (2015), 1–5.
18. Reddi, S., Shanmugam, V.P., Kapila, S., Kapila, R., Identification of buffalo casein-derived bioactive peptides with osteoblast proliferation activity. Eur Food Res Technol 242 (2016), 2139–2146.
19. Reddi, S., Kumar, N., Vij, R., Mada, S.B., Kapila, S., Kapila, R., Akt drives buffalo casein-derived novel peptide mediated osteoblast differentiation. J Nutr Biochem 38 (2016), 134–144.
20. Vij, R., Reddi, S., Kapila, S., Kapila, R., Transepithelial transport of milk derived bioactive peptide VLPVPQK. Food Chem 190 (2016), 681–688.
21. Mada, S.B., Reddi, S., Kumar, N., Kapila, S., Kapila, R., Protective effects of casein-derived peptide VLPVPQK against hydrogen peroxide–induced dysfunction and cellular oxidative damage in rat osteoblastic cells. Hum Exp Toxicol, 2017 http://dx.doi.org/10.1177/0960327116678293 [E-pub ahead of print].
22. Trivedi, R., Kumar, A., Gupta, V., Kumar, S., Nagar, G.K., Romero, J.R., et al. Effects of Egb 761 on bone mineral density, bone microstructure, and osteoblast function: Possible roles of quercetin and kaempferol. Mol Cell Endocrinol 302 (2009), 86–91.
23. Trivedi, R., Kumar, S., Kumar, A., Siddiqui, J.A., Swarnkar, G., Gupta, V., et al. Kaempferol has osteogenic effect in ovariectomized adult Sprague–Dawley rats. Mol Cell Endocrinol 289 (2008), 85–93.
24. AOAC, Official methods of analysis 18th ed of Association of Official Analytical Chemists. 2005, AOAC, Gaithersburg, MD.
25. Kushwaha, P., Khedgikar, V., Sharma, D., Yuen, T., Gautam, J., Ahmad, N., et al. MicroRNA-874-3 p exerts skeletal anabolic effects epigenetically during weaning by suppressing Hdac1. J Biol Chem 291 (2016), 3959–3966.
26. Bhargava, B., Gautam, A.K., Singh, D., Kumar, A., Chaurasia, S., Tyagi, A.M., et al. Methoxylated isoflavones, cajanin and isoformononetin, have non-estrogenicbone forming effect via differential mitogen activated protein kinase (MAPK) signaling. J Cell Biochem 108 (2009), 388–399.
27. Akcakaya, H., Aroymak, A., Gokce, S., A quantitative colorimetric method of measuring alkaline phosphatase activity in eukaryotic cell membranes. Cell Biol Int 31 (2007), 186–190.
28. Lowry, O.H., Rosebrough, N.J., Farr, A.L., Randall, R.J., Protein measurement with the folin phenol reagent. J Biol Chem 193 (1951), 265–275.
29. Uchiyama, M., Mihara, M., Determination of malondialdehyde precursors in tissues by thiobarbituric acid test. Anal Biochem 86 (1978), 271–278.
30. Ellman, G.L., Fiches, F.T., Quantitative determination of peptides by sulfhydryl groups. Arch Biochem Biophys 82 (1959), 70–72.
31. Aebi, H., Catalase in vitro. Methods Enzymol 105 (1984), 121–126.
32. Marklund, S., Marklund, G., Involvement of the superoxide anion radical in the autoxidation of pyrogallol and a convenient assay for superoxide dismutase. Eur J Biochem 47 (1974), 469–474.
33. Li, X., Song, Q.S., Wang, J.Y., Leng, H.J., Chen, Z.Q., Liu, Z.J., et al. Simvastatin induces estrogen receptor-alpha expression in bone, restores bone loss, and decreases ERalpha expression and uterine wet weight in ovariectomized rats. J Bone Miner Metab 29 (2011), 396–403.
34. Borst, S.E., Conover, C.F., Carter, C.S., Gregory, C.M., Marzetti, E., Leeuwenburgh, C., et al. Anabolic effects of testosterone are preserved during inhibition of 5-alpha reductase. Am J Physiol Endocrinol Metab 293 (2007), 507–514.
35. Elkomy, M.M., Elsaid, F.G., Anti-osteoporotic effect of medical herbs and calcium supplementation on ovariectomized rats. JOBAZ 72 (2015), 81–88.
36. Kim, T.H., Jung, J.W., Ha, B.G., Hong, J.M., Park, E.K., Kim, H.J., et al. The effects of luteolin on osteoclast differentiation, function in vitro and ovariectomy-induced bone loss. J Nutr Biochem 22 (2011), 8–15.
37. Chappard, D., Basle, M.F., Legrand, E., Audran, M., Trabecular bone microarchitecture: a review. Morphologie 92 (2008), 162–170.
38. Keaveny, T.M., McClung, M.R., Genant, H.K., Zanchetta, J.R., Kendler, D., Brown, J.P., et al. Femoral and vertebral strength improvements in postmenopausal women with osteoporosis treated with denosumab. J Bone Miner Res 29 (2014), 158–165.
39. Sara, F., Saygili, F., Causes of high bone alkaline phosphatase. Biotechnol Biotechnol Equip 21 (2007), 194–197.
40. Guillerminet, F., Beaupied, H., Fabien-Soule, V., Tome, D., Benhamou, C., Roux, C., Hydrolyzed collagen improves bone metabolism and biomechanical parameters in ovariectomized mice: an in vitro and in vivo study. Bone 46 (2009), 827–834.
41. Choi, M.J., Seo, J.N., Effect of taurine feeding on bone mineral density and bone markers in rats. Adv Exp Med Biol 776 (2013), 51–58.
42. Cashman, K.D., Calcium intake, calcium bioavailability and bone health. Br J Nutr 87 (2002), S169–S177.
43. Sheweita, S.A., Khoshhal, K.I., Calcium metabolism and oxidative stress in bone fractures: role of antioxidants. Curr Drug Metab 8 (2007), 519–525.
44. Khajuria, D.K., Razdan, R., Mahapatra, D.R., Additive effects of zoledronic acid and propranolol on bone density and biochemical markers of bone turnover in osteopenic ovariectomized rats. Rev Bras Reumatol 55 (2015), 103–112.
45. Ross, F.P., Chappel, J., Alvarez, J.I., Sander, D., Butler, W.D., Farach-Carson, M.C., et al. Interactions between the bone matrix proteins osteopontin and bone sialoprotein and the osteoclast integrin αvβ3 potentiate bone resorption. J Biol Chem 268 (1993), 9901–9907.
46. Jagtap, V.R., Ganu, J.V., Nagane, N.S., BMD and serum intact osteocalcin in postmenopausal osteoporosis women. Indian J Clin Biochem 26 (2011), 70–73.
47. Narva, M., Rissanen, J., Halleen, J., Vapaatalo, H., Vaananen, K., Korpela, R., Effects of bioactive peptide, valyl-prolyl-proline (VPP), and Lactobacillus helveticus fermented milk containing VPP on bone loss in ovariectomized rats. Ann Nutr Metab 51 (2007), 65–74.
48. Lacey, D.L., Timms, E., Tan, H.L., Kelley, M.J., Dunstan, C.R., Burgess, T., et al. Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation. Cell 93 (1998), 165–176.
49. Boyle, W.J., Simonet, W.S., Lacey, D.L., Osteoclast differentiation and activation. Nature 423 (2003), 337–342.
50. Boyce, B.F., Xing, L., Biology of RANK, RANKL, and osteoprotegerin. Arthritis Res Ther, 9, 2007, S1.
51. Tang, Y., Wu, X., Lei, W., Pang, L., Wan, C., Shi, Z., et al. TGF-β1-induced migration of bone mesenchymal stem cells couples bone resorption and formation. Nat Med 15 (2009), 757–765.
52. Kitazawa, R., Kimble, R.B., Vannice, J.L., Kung, V.T., Pacifici, R., Interleukin-1 receptor antagonist and tumor necrosis factor binding protein decrease osteoclast formation and bone resorption in ovariectomized mice. J Clin Invest 94 (1994), 2397–2406.
53. Abuohashish, H.M., Ahmed, M.M., Al-Rejaie1 SS, El-tahir KEH. Antidepressant bupropion exerts alleviating properties in an ovariectomized osteoporotic rat model. Acta Pharmacol Sin 36 (2015), 209–220.
54. Cakatay, U., Aydin, S., Yanar, K., Uzun, H., Gender-dependent variations in systemic biomarkers of oxidative protein, DNA, and lipid damage in aged rats. Aging Male 13 (2010), 51–58.
55. Sendur, O.F., Turan, Y., Tastaban, E., Serter, M., Antioxidant status in patients with osteoporosis: a controlled study. Joint Bone Spine 76 (2009), 514–518.
56. Manolagas, S.C., From estrogen-centric to aging and oxidative stress: a revised perspective of the pathogenesis of osteoporosis. Endocr Rev 31 (2010), 266–300.
57. Estrela, J.M., Ortega, A., Obrador, E., Glutathione in cancer biology and therapy. Crit Rev Clin Lab Sci 43 (2006), 143–181.
58. Lee, Y.M., Cheng, T.P., Hong, S.F., Chen, S.Y., Lam, K.K., Sheu, J.R., et al. Oxidative stress induces vascular heme oxygenase-1 expression in ovariectomized rats. Free Radic Biol Med 39 (2005), 108–117.